
Around 195,000 people globally will be treated for this form of lung cancer in 2026

This is the first and only perioperative immunotherapy approved to treat early gastric cancers

Gastric cancer is the fifth highest cause of cancer deaths worldwide, with almost a million people diagnosed annually

The company has invested $40bn in US R&D and manufacturing in the past seven years

In 2022, nearly one million new patients were diagnosed with gastric cancer

The study found significant reductions of major cardiovascular events in high-risk adults following treatment

The investment is expected to generate up to 750 new jobs

The phase 3 study included around 2,600 patients

Gastric cancer is the fifth leading cause of cancer-related deaths globally

Almost one million new cases of gastric cancer are diagnosed globally every year

Immunoglobulin G4-related disease affects approximately 20,000 people in the US

Regulatory submissions are expected to be complete in the first half of this year